Mitochondrial dysfunction may be a principal underlying event in aging, including age-associated brain degeneration. Mitochondria provide energy for basic metabolic processes. Their decay with age impairs cellular metabolism and leads to a decline of cellular function. Alzheimer disease (AD) and cerebrovascular accidents (CVAs) are two leading causes of age-related dementia. Increasing evidence strongly supports the theory that oxidative stress, largely due to reactive oxygen species (ROS), induces mitochondrial damage, which arises from chronic hypoperfusion and is primarily responsible for the pathogenesis that underlies both disease processes. Mitochondrial membrane potential, respiratory control ratios and cellular oxygen consumption decline with age and correlate with increased oxidant production. The sustained hypoperfusion and oxidative stress in brain tissues can stimulate the expression of nitric oxide synthases (NOSs) and brain endothelium probably increase the accumulation of oxidative stress products, which therefore contributes to blood brain barrier (BBB) breakdown and brain parenchymal cell damage. Determining the mechanisms behind these imbalances may provide crucial information in the development of new, more effective therapies for stroke and AD patients in the near future.
References
[1]
Aliev, G.; Smith, M.A.; Seyidov, D.; Neal, M.L.; Lamb, B.T.; Nunomura, A.; Gasimov, E.K.; Vinters, H.V.; Perry, G.; LaManna, J.C.; Friedland, R.P. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol.？2002, 12, 21–35. 11770899
[2]
Aliev, G.; Gasimov, E.; Obrenovich, M.E.; Fischbach, K.; Shenk, J.C.; Smith, M.A.; Perry, G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc. Health Risk Manag.？2008, 4, 721–730. 18827923
[3]
Aliev, G.; Palacios, H.H.; Walrafen, B.; Lipsitt, A.E.; Obrenovich, M.E.; Morales, L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int. J. Biochem. Cell Biol.？2009, 41, 1989–2004, doi:10.1016/j.biocel.2009.03.015. 19703659
[4]
De la Torre, J.C. Cerebrovascular and cardiovascular pathology in Alzheimer's disease. Int. Rev. Neurobiol.？2009, 84, 35–48. 19501712
[5]
Kalaria, R.N. The blood–brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann. N. Y. Acad. Sci.？1999, 893, 113–125, doi:10.1111/j.1749-6632.1999.tb07821.x. 10672233
[6]
Kalaria, R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging？2000, 21, 321–330, doi:10.1016/S0197-4580(00)00125-1. 10867217
[7]
Aliev, G.; Palacios, H.H.; Lipsitt, A.E.; Fischbach, K.; Lamb, B.T.; Obrenovich, M.E.; Morales, L.; Gasimov, E.; Bragin, V. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox. Res.？2009, 16, 293–305, doi:10.1007/s12640-009-9066-5. 19526276
[8]
Aliev, G. Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences? J. Alzheimer’s Dis.？2002, 4, 513–516.
[9]
Aliev, G.; Cirillo, R.; Salvatico, E.; Paro, M.; Prosdocimi, M. Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention. Microvasc. Res.？1993, 46, 65–76, doi:10.1006/mvre.1993.1035. 8412853
[10]
De la Torre, J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke？2002, 33, 1152–1162, doi:10.1161/01.STR.0000014421.15948.67. 11935076
[11]
Aliev, G.; Obrenovich, M.E.; Reddy, V.P.; Shenk, J.C.; Moreira, P.I.; Nunomura, A.; Zhu, X.; Smith, M.A.; Perry, G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev. Med. Chem.？2008, 8, 1395–1406.
[12]
Lum, H.; Roebuck, K.A. Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell Physiol.？2001, 280, C719–C741. 11245588
[13]
Coyle, J.T.; Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science？1993, 262, 689–695. 7901908
[14]
Perry, G.; Smith, M.A.; McCann, C.E.; Siedlak, S.L.; Jones, P.K.; Friedland, R.P. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res.？1998, 791, 63–66, doi:10.1016/S0006-8993(98)00006-7. 9593825
Smith, M.A.; Petot, G.J.; Perry, G. Commentary: Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease. Alzheimer's Dis. Rev.？1997, 2, 58–60.
[17]
Smith, M.A.; Richey Harris, P.L.; Sayre, L.M.; Beckman, J.S.; Perry, G. Widespread peroxynitrite–mediated damage in Alzheimer's disease. J. Neurosci.？1997, 17, 2653–2657. 9092586
Prelli, F.; Castano, E.M.; van Duinen, S.G.; Bots, G.T.; Luyendijk, W.; Frangione, B. Different processing of Alzheimer's beta–protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis–Dutch type. Biochem. Biophys. Res. Commun.？1988, 151, 1150–1155, doi:10.1016/S0006-291X(88)80486-8. 3281669
Mecocci, P.; Beal, M.F.; Cecchetti, R.; Polidori, M.C.; Cherubini, A.; Chionne, F.; Avellini, L.; Romano, G.; Senin, U. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol.？1997, 31, 53–64, doi:10.1007/BF02815160. 9271005
[27]
Mecocci, P.; MacGarvey, U.; Beal, M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol.？1994, 36, 747–751, doi:10.1002/ana.410360510. 7979220
[28]
Mecocci, P.; MacGarvey, U.; Kaufman, A.E.; Koontz, D.; Shoffner, J.M.; Wallace, D.C.; Beal, M.F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol.？1993, 34, 609–616, doi:10.1002/ana.410340416. 8215249
[29]
Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C.S.; Petersen, R.B.; Smith, M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol.？2001, 60, 759–767. 11487050
[30]
Nunomura, A.; Perry, G.; Hirai, K.; Aliev, G.; Takeda, A.; Chiba, S.; Smith, M.A. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann. N. Y. Acad. Sci.？1999, 893, 362–364, doi:10.1111/j.1749-6632.1999.tb07855.x. 10672267
[31]
Nunomura, A.; Perry, G.; Pappolla, M.A.; Wade, R.; Hirai, K.; Chiba, S.; Smith, M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci.？1999, 19, 1959–1964. 10066249
[32]
Perry, G.; Nunomura, A.; Hirai, K.; Takeda, A.; Aliev, G.; Smith, M.A. Oxidative damage in Alzheimer's disease: the metabolic dimension. Int. J. Dev. Neurosci.？2000, 18, 417–421, doi:10.1016/S0736-5748(00)00006-X. 10817925
[33]
Sayre, L.M.; Zelasko, D.A.; Harris, P.L.; Perry, G.; Salomon, R.G.; Smith, M.A. 4–Hydroxynonenal–derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem.？1997, 68, 2092–2097. 9109537
[34]
Smith, M.A.; Taneda, S.; Richey, P.L.; Miyata, S.; Yan, S.D.; Stern, D.; Sayre, L.M.; Monnier, V.M.; Perry, G. Advanced Maillard reaction end products are associated with Alzheimer’s disease pathology. Proc. Natl. Acad. Sci, USA？1994, 91, 5710–5714, doi:10.1073/pnas.91.12.5710.
[35]
Cirillo, R.; Aliev, G.; Hornby, E.J.; Prosdocimi, M. Endothelium as a therapeutical target in peripheral occlusive arterial diseases: consideration for pharmacological interventions. Pharmacol. Res.？1994, 29, 293–311, doi:10.1016/1043-6618(94)80053-7. 7971683
[36]
Cirillo, R.; Salvatico, E.; Aliev, G.; Prosdocimi, M. Effect of cloricromene during ischemia and reperfusion of rabbit hindlimb: evidence for an involvement of leukocytes in reperfusion–mediated tissue and vascular injury. J. Cardiovasc. Pharmacol.？1992, 20, 969–975, doi:10.1097/00005344-199212000-00018. 1282601
[37]
Granger, D.N.; Benoit, J.N.; Suzuki, M.; Grisham, M.B. Leukocyte adherence to venular endothelium during ischemia–reperfusion. Am. J. Physiol.？1989, 257, G683–G688. 2596604
[38]
Sala, A.; Aliev, G.M.; Rossoni, G.; Berti, F.; Buccellati, C.; Burnstock, G.; Folco, G.; Maclouf, J. Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit. Blood？1996, 87, 1824–1832. 8634429
[39]
Salvatico, E.; Aliev, G.M.; Novello, D.; Prosdocimi, M. Functional depression of isolated perfused rat heart mediated by activated leukocytes: protective effect of cloricromene. J. Cardiovasc. Pharmacol.？1994, 24, 638–647, doi:10.1097/00005344-199410000-00015. 7528847
[40]
Matz, R.L.; Schott, C.; Stoclet, J.C.; Andriantsitohaina, R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium–derived hyperpolarizing factor and cyclooxygenase products. Physiol. Res.？2000, 49, 11–18. 10805400
[41]
Aliev, G.; Burnstock, G. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histol. Histopathol.？1998, 13, 797–817. 9690137
[42]
Stewart–Lee, A.L.; Ferns, G.A.; Anggard, E.E. Differences in onset of impaired endothelial responses and in effects of vitamin E in the hypercholesterolemic rabbit carotid and renal arteries. J. Cardiovasc. Pharmacol.？1995, 25, 906–913, doi:10.1097/00005344-199506000-00008. 7564335
[43]
Price, J.M.; Sutton, E.T.; Hellermann, A.; Thomas, T. beta–Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurol. Res.？1997, 19, 534–538. 9329032
Niwa, K.; Carlson, G.A.; Iadecola, C. Exogenous a beta1–40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J. Cereb. Blood Flow Metab.？2000, 20, 1659–1668, doi:10.1097/00004647-200012000-00005. 11129782
[46]
Grammas, P.; Moore, P.; Weigel, P.H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol.？1999, 154, 337–342. 10027392
[47]
Mao, P.; Reddy, P.H. Is multiple sclerosis a mitochondrial disease? Biochim. Biophys. Acta？2009, 1802, 66–79. 19607913
[48]
Acuna–Castroviejo, D.; Martin, M.; Macias, M.; Escames, G.; Leon, J.; Khaldy, H.; Reiter, R.J. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res.？2001, 30, 65–74. 11270481
[49]
Castellani, R.; Hirai, K.; Aliev, G.; Drew, K.L.; Nunomura, A.; Takeda, A.; Cash, A.D.; Obrenovich, M.E.; Perry, G.; Smith, M.A. Role of mitochondrial dysfunction in Alzheimer's disease. J. Neurosci. Res.？2002, 70, 357–360, doi:10.1002/jnr.10389. 12391597
[50]
Fiskum, G.; Murphy, A.N.; Beal, M.F. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab.？1999, 19, 351–369, doi:10.1097/00004647-199904000-00001. 10197505
[51]
Schulz, J.B.; Matthews, R.T.; Klockgether, T.; Dichgans, J.; Beal, M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell Biochem.？1997, 174, 193–197, doi:10.1023/A:1006852306789. 9309687
[52]
Vancova, O.; Baciak, L.; Kasparova, S.; Kucharska, J.; Palacios, H.H.; Horecky, J.; Aliev, G. In vivo？and？in vitro？assessment of brain bioenergetics in aging rats. JCMM？2009.
Horecky, J.; Baciak, L.; Kasparova, S.; Pacheco, G.; Aliev, G.; Vancova, O. Minimally invasive surgical approach for three–vessel occlusion as a model of vascular dementia in the rat–brain bioenergetics assay. J. Neurol. Sci.？2009, 283, 178–181, doi:10.1016/j.jns.2009.02.348. 19272617
[55]
Beckman, K.B.; Ames, B.N. The free radical theory of aging matures. Physiol. Rev.？1998, 78, 547–581. 9562038
[56]
Beckman, K.B.; Ames, B.N. Mitochondrial aging: open questions. Ann. N.Y. Acad. Sci.？1998, 854, 118–127, doi:10.1111/j.1749-6632.1998.tb09897.x. 9928425
Aliev, G.; Smith, M.A.; Obrenovich, M.E.; de la Torre, J.C.; Perry, G. Role of vascular Hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer’s disease. Neurotox. Res.？2003, 5, 491–504, doi:10.1007/BF03033159. 14715433
[63]
Al–Abdulla, N.A.; Martin, L.J. Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am. J. Pathol.？1998, 153, 447–456. 9708805
[64]
Wallace, D.C. Mitochondrial DNA in aging and disease. Sci. Am.？1997, 277, 40–47, doi:10.1038/scientificamerican0897-40. 9245840
[65]
Cormier, A.; Morin, C.; Zini, R.; Tillement, J.P.; Lagrue, G. In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res.？2001, 900, 72–79, doi:10.1016/S0006-8993(01)02254-5. 11325348
[66]
Reddy, P.H. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. C.N.S. Spectr.？2009, 14, 8–18.
[67]
Aliyev, A.; Chen, S.G.; Seyidova, D.; Smith, M.A.; Perry, G.; de la Torre, J.; Aliev, G. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J. Neurol. Sci.？2005, 229-230, 285–292, doi:10.1016/j.jns.2004.11.040. 15760652
[68]
De Jong, G.I.; De Vos, R.A.; Steur, E.N.; Luiten, P.G. Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies. Ann. N.Y. Acad. Sci.？1997, 826, 56–74.
[69]
De la Torre, J.C. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. N.Y. Acad. Sci.？1997, 826, 75–91, doi:10.1111/j.1749-6632.1997.tb48462.x. 9329682
[70]
Friston, K.J.; Frackowiak, R.S. Cerebral function in aging and Alzheimer's disease: the role of PET. Electroencephalogr. Clin. Neurophysiol. Suppl.？1991, 42, 355–365. 1915028
[71]
Kumar, A.; Schapiro, M.B.; Haxby, J.V.; Grady, C.L.; Friedland, R.P. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features. J. Psychiatr. Res.？1990, 24, 97–109, doi:10.1016/0022-3956(90)90050-Z. 2213642
[72]
Galle, J.; Bengen, J.; Schollmeyer, P.; Wanner, C. Impairment of endothelium–dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen–derived radicals. Circulation？1995, 92, 1582–1589. 7664444
[73]
de la Torre, J.C.; Stefano, G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Brain Res. Rev.？2000, 34, 119–136, doi:10.1016/S0165-0173(00)00043-6.
[74]
Meguro, K.; Blaizot, X.; Kondoh, Y.; Le Mestric, C.; Baron, J.C.; Chavoix, C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non–human primate as shown by PET. Implications for Alzheimer's disease. Brain？1999, 122 (Pt. 8), 1519–1531. 10430835
[75]
Jagust, W.J.; Friedland, R.P.; Budinger, T.F.; Koss, E.; Ober, B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology？1988, 38, 909–912. 3259296
[76]
de la Torre, J.C. Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener. Dis.？2008, 5, 126–132, doi:10.1159/000113681. 18322369
[77]
de la Torre, J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke？2002, 33, 1152–1162, doi:10.1161/01.STR.0000014421.15948.67. 11935076
[78]
De la Torre, J.C. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Ann. N.Y. Acad. Sci.？2000, 903, 424–436, doi:10.1111/j.1749-6632.2000.tb06394.x. 10818533
[79]
De la Torre, J.C. Alzheimer's disease prevalence can be lowered with non–invasive testing. J. Alzheimer's Dis.？2008, 14, 353–359.
[80]
Hofman, A.; Ott, A.; Breteler, M.M.; Bots, M.L.; Slooter, A.J.; van Harskamp, F.; van Duijn, C.N.; Van Broeckhoven, C.; Grobbee, D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet？1997, 349, 151–154, doi:10.1016/S0140-6736(96)09328-2. 9111537
[81]
Weinbrecht, P.; Longmuir, I.; Knopp, J.; Mills, M. Cerebral microcirculatory changes during exposure to hypoxia. Adv. Exp. Med. Biol.？1987, 215, 259–263. 3673725
[82]
Mironov, V.; Hritz, M.A.; LaManna, J.C.; Hudetz, A.G.; Harik, S.I. Architectural alterations in rat cerebral microvessels after hypobaric hypoxia. Brain Res.？1994, 660, 73–80, doi:10.1016/0006-8993(94)90840-0. 7828003
[83]
Chavez, J.C.; Agani, F.; Pichiule, P.; LaManna, J.C. Expression of hypoxia–inducible factor–1 alpha in the brain of rats during chronic hypoxia. J. Appl. Physiol.？2000, 89, 1937–1942. 11053346
LaManna, J.C.; Boehm, K.D.; Mironov, V.; Hudetz, A.G.; Hritz, M.A.; Yun, J.K.; Harik, S.I. Increased basic fibroblastic growth factor mRNA in the brains of rats exposed to hypobaric hypoxia. Adv. Exp. Med. Biol.？1994, 361, 497–502. 7597975
[86]
Harik, N.; Harik, S.I.; Kuo, N.T.; Sakai, K.; Przybylski, R.J.; LaManna, J.C. Time–course and reversibility of the hypoxia–induced alterations in cerebral vascularity and cerebral capillary glucose transporter density. Brain Res.？1996, 737, 335–338, doi:10.1016/0006-8993(96)00965-1. 8930387
[87]
Zhu, X.; Smith, M.A.; Perry, G.; Aliev, G. Mitochondrial failures in Alzheimer's disease. Am. J. Alzheimer’s Dis. Other Demen.？2004, 19, 345–352, doi:10.1177/153331750401900611.
[88]
Aliev, G.; Smith, M.A.; Turmaine, M.; Neal, M.L.; Zimina, T.V.; Friedland, R.P.; Perry, G.; LaManna, J.C.; Burnstock, G. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin–1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Exp. Mol. Pathol.？2001, 71, 40–54, doi:10.1006/exmp.2001.2380. 11502096
[89]
Shi, J.; Perry, G.; Berridge, M.S.; Aliev, G.; Siedlak, S.L.; Smith, M.A.; LaManna, J.C.; Friedland, R.P. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. JNM？2002, 43, 1044–1051. 12163630
[90]
Bednar, M.M.; Raymond, S.; McAuliffe, T.; Lodge, P.A.; Gross, C.E. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke？1991, 22, 44–50. 1987672
[91]
Chen, H.; Chopp, M.; Zhang, Z.G.; Garcia, J.H. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab.？1992, 12, 621–628. 1618941
[92]
Olah, L.; Wecker, S.; Hoehn, M. Relation of apparent diffusion coefficient changes and metabolic disturbances after 1 hour of focal cerebral ischemia and at different reperfusion phases in rats. J. Cereb. Blood Flow Metab.？2001, 21, 430–439, doi:10.1097/00004647-200104000-00012. 11323529
[93]
Dietrich, W.D.; Busto, R.; Ginsberg, M.D. Cerebral endothelial microvilli: formation following global forebrain ischemia. J. Neuropathol. Exp. Neurol.？1984, 43, 72–83, doi:10.1097/00005072-198401000-00006. 6693929
[94]
Fischer, E.G.; Ames 3d, A. Studies on mechanisms of impairment of cerebral circulation following ischemia: effect of hemodilution and perfusion pressure. Stroke？1972, 3, 538–542. 4652728
[95]
Wade, J.G.; Amtorp, O.; Sorensen, S.C. No–flow state following cerebral ischemia.Role of increase in potassium concentration in brain interstitial fluid. Arch. Neurol.？1975, 32, 381–384. 1131072
[96]
Cada, A.; de la Torre, J.C.; Gonzalez–Lima, F. Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior. Neurobiol. Aging？2000, 21, 225–233, doi:10.1016/S0197-4580(00)00116-0. 10867207
[97]
Marletta, M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell？1994, 78, 927–930, doi:10.1016/0092-8674(94)90268-2. 7522970
[98]
Moncada, S.; Higgs, E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J.？1995, 9, 1319–1330. 7557022
Crow, J.P.; Ye, Y.Z.; Strong, M.; Kirk, M.; Barnes, S.; Beckman, J.S. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament L. J. Neurochem.？1997, 69, 1945–1953. 9349539
Michel, T.; Feron, O. Nitric oxide synthases: which, where, how, and why? J. Clin. Invest.？1997, 100, 2146–2152, doi:10.1172/JCI119750. 9410890
[105]
Wever, R.M.; Luscher, T.F.; Cosentino, F.; Rabelink, T.J. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation？1998, 97, 108–112. 9443438
[106]
Xia, Y.; Dawson, V.L.; Dawson, T.M.; Snyder, S.H.; Zweier, J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine–depleted cells leading to peroxynitrite–mediated cellular injury. Proc. Natl. Acad. Sci. USA？1996, 93, 6770–6774, doi:10.1073/pnas.93.13.6770.
[107]
Ignarro, L.J. Biosynthesis and metabolism of endothelium–derived nitric oxide. Annu. Rev . Pharmacol. Toxicol.？1990, 30, 535–560. 2188578
[108]
Stamler, J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell？1994, 78, 931–936, doi:10.1016/0092-8674(94)90269-0. 7923362
[109]
Robinson, L.J.; Weremowicz, S.; Morton, C.C.; Michel, T. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics？1994, 19, 350–357, doi:10.1006/geno.1994.1068. 7514568
[110]
Sessa, W.C. The nitric oxide synthase family of proteins. J. Vasc. Res.？1994, 31, 131–143, doi:10.1159/000159039. 7511942
[111]
Stuehr, D.J. Structure–function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol.？1997, 37, 339–359, doi:10.1146/annurev.pharmtox.37.1.339. 9131257
[112]
Morris Jr., S.M.; Billiar, T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol.？1994, 266, E829–E839. 8023911
[113]
Bates, T.E.; Loesch, A.; Burnstock, G.; Clark, J.B. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem. Biophys. Res. Commun.？1995, 213, 896–900, doi:10.1006/bbrc.1995.2213. 7544582
Cazevieille, C.; Muller, A.; Meynier, F.; Bonne, C. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation–induced neuron injury. Free Radic. Biol. Med.？1993, 14, 389–395, doi:10.1016/0891-5849(93)90088-C. 8096826
[123]
Radi, R.; Beckman, J.S.; Bush, K.M.; Freeman, B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem.？1991, 266, 4244–4250. 1847917
[124]
Lafon–Cazal, M.; Pietri, S.; Culcasi, M.; Bockaert, J. NMDA–dependent superoxide production and neurotoxicity. Nature？1993, 364, 535–537, doi:10.1038/364535a0. 7687749
[125]
Faraci, F.M. Role of endothelium–derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am. J. Physiol.？1991, 261, H1038–H1042. 1928387
[126]
Fabricius, M.; Lauritzen, M. Examination of the role of nitric oxide for the hypercapnic rise of cerebral blood flow in rats. Am. J. Physiol.？1994, 266, H1457–H1464. 8184923
[127]
Iadecola, C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc. Natl. Acad. Sci. USA？1992, 89, 3913–3916, doi:10.1073/pnas.89.9.3913.
[128]
Buisson, A.; Margaill, I.; Callebert, J.; Plotkine, M.; Boulu, R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem.？1993, 61, 690–696. 7687658
[129]
Buisson, A.; Plotkine, M.; Boulu, R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol.？1992, 106, 766–767. 1382786
[130]
Samadani, A.F.; Dawson, T.M.; Dawson, V.L. Nitric oxide synthase in model of focal ischemia. Stroke？1997, 28, 1283–1288. 9183363
[131]
Hamada, Y.; Hayakawa, T.; Hattori, H.; Mikawa, H. Inhibitor of nitric oxide synthesis reduces hypoxic–ischemic brain damage in the neonatal rat. Pediatr. Res.？1994, 35, 10–14, doi:10.1203/00006450-199401000-00003. 8134185
[132]
Iadecola, C.; Li, J.; Ebner, T.J.; Xu, X. Nitric oxide contributes to functional hyperemia in cerebellar cortex. Am. J. Physiol.？1995, 268, R1153–R1162. 7539595
Iadecola, C.; Zhang, F.; Xu, S.; Casey, R.; Ross, M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab.？1995, 15, 378–384. 7536197
[135]
Nakashima, M.N.; Yamashita, K.; Kataoka, Y.; Yamashita, Y.S.; Niwa, M. Time course of nitric oxide synthase activity in neuronal, glial, and endothelial cells of rat striatum following focal cerebral ischemia. Cell Mol. Neurobiol.？1995, 15, 341–349, doi:10.1007/BF02089944. 7553733
[136]
Wang, Q.; Pelligrino, D.A.; Baughman, V.L.; Koenig, H.M.; Albrecht, R.F. The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb. Blood Flow Metab.？1995, 15, 774–778. 7545691
[137]
Garthwaite, J.; Beaumont, P.S. Excitatory amino acid receptors in the parallel fibre pathway in rat cerebellar slices. Neurosci. Lett.？1989, 107, 151–156, doi:10.1016/0304-3940(89)90808-2. 2575725
[138]
Hara, H.; Huang, P.L.; Panahian, N.; Fishman, M.C.; Moskowitz, M.A. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab.？1996, 16, 605–611, doi:10.1097/00004647-199607000-00010. 8964799
[139]
Huang, Z.; Huang, P.L.; Panahian, N.; Dalkara, T.; Fishman, M.C.; Moskowitz, M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science？1994, 265, 1883–1885. 7522345
Thorns, V.; Hansen, L.; Masliah, E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp. Neurol.？1998, 150, 14–20, doi:10.1006/exnr.1997.6751. 9514829
[142]
Bogumil, R.; Knipp, M.; Fundel, S.M.; Vasak, M. Characterization of dimethylargininase from bovine brain: evidence for a zinc binding site. Biochemistry？1998, 37, 4791–4798, doi:10.1021/bi972312t. 9537995
[143]
Kimoto, M.; Tsuji, H.; Ogawa, T.; Sasaoka, K. Detection of NG,NG–dimethylarginine dimethylaminohydrolase in the nitric oxide–generating systems of rats using monoclonal antibody. Arch. Biochem. Biophys.？1993, 300, 657–662, doi:10.1006/abbi.1993.1091. 8434946
[144]
Kimoto, M.; Whitley, G.S.; Tsuji, H.; Ogawa, T. Detection of NG,NG–dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J. Biochem. (Tokyo)？1995, 117, 237–238.
[145]
MacAllister, R.J.; Parry, H.; Kimoto, M.; Ogawa, T.; Russell, R.J.; Hodson, H.; Whitley, G.S.; Vallance, P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol.？1996, 119, 1533–1540. 8982498
[146]
Beckman, J.S.; Carson, M.; Smith, C.D.; Koppenol, W.H. ALS, SOD and peroxynitrite. Nature？1993, 364, 584, doi:10.1038/364584a0. 8350919
Ames, B.N. Delaying the mitochondrial decay of aging. Ann. N.Y. Acad. Sci.？2004, 1019, 406–411, doi:10.1196/annals.1297.073. 15247055
[149]
Ames, B.N. Mitochondrial decay, a major cause of aging, can be delayed. J. Alzheimer's Dis.？2004, 6, 117–121.
[150]
Ames, B.N.; Liu, J. Delaying the mitochondrial decay of aging with acetyl L-Carnitine. Ann. N.Y. Acad. Sci.？2004, 1033, 108–116, doi:10.1196/annals.1320.010. 15591008
[151]
Liu, J.; Head, E.; Gharib, A.M.; Yuan, W.; Ingersoll, R.T.; Hagen, T.M.; Cotman, C.W.; Ames, B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl–L–carnitine and/or R–alpha –lipoic acid. Proc. Natl. Acad. Sci. USA？2002, 99, 2356–2361, doi:10.1073/pnas.261709299.
[152]
Liu, J.; Head, E.; Kuratsune, H.; Cotman, C.W.; Ames, B.N. Comparison of the effects of L–carnitine and acetyl–L–carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann. N.Y. Acad. Sci.？2004, 1033, 117–131, doi:10.1196/annals.1320.011. 15591009
[153]
Milgram, N.W.; Araujo, J.A.; Hagen, T.M.; Treadwell, B.V.; Ames, B.N. Acetyl–L–Carnitine and alpha–Lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. FASEB J.？2007, 21, 3756–3762, doi:10.1096/fj.07-8531com. 17622567
[154]
Shenk, J.C.; Liu, J.; Fischbach, K; Xu, K.; Puchowicz, M.; Obrenovich, M.E; Gasimov, E.; Alvarez, L,M.; Ames, B.N.; LaManna, J.C.; Aliev, G. The effect of acetyl–L–Carnitine and R–Lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J. Neurol. Sci.？2009, 283, 199–206, doi:10.1016/j.jns.2009.03.002. 19342064
[155]
Gomez–Pinilla, F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci.？2008, 9, 568–578, doi:10.1038/nrn2421. 18568016
[156]
Reddy, P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol.？2009, 218, 286–292, doi:10.1016/j.expneurol.2009.03.042. 19358844
[157]
Liu, J.; Killilea, D.W.; Ames, B.N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate–binding affinity and activity in brain by feeding old rats acetyl–L–Carnitine and/or R–alpha–Lipoic acid. Proc. Natl. Acad. Sci. USA？2002, 99, 1876–1881, doi:10.1073/pnas.261709098.
[158]
Long, J.; Gao, F.; Tong, L.; Cotman, C.W.; Ames, B.N.; Liu, J. Mitochondrial decay in the brains of old rats: ameliorating effect of alpha–Lipoic acid and acetyl–L–Carnitine. Neurochem. Res.？2009, 34, 755–63, doi:10.1007/s11064-008-9850-2. 18846423
[159]
Reddy, P.H.; Beal, M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med.？2008, 14, 45–53, doi:10.1016/j.molmed.2007.12.002. 18218341
[160]
Reddy, P.H. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med.？2008, 10, 291–315, doi:10.1007/s12017-008-8044-z. 18566920
[161]
Reddy, P.H. Amyloid precursor protein–mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem.？2006, 96, 1–13, doi:10.1111/j.1471-4159.2005.03530.x. 16305625
[162]
Liu, J.; Atamna, H.; Kuratsune, H.; Ames, B.N. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. N.Y. Acad. Sci.？2002, 959, 133–166. 11976193
[163]
Reid, P.C.; Urano, Y.; Kodama, T.; Hamakubo, T. Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. JCMM？2007, 11, 383–392. 17635634
[164]
Aliev, G.; Shenk, J.C.; Fischbach, K.; Perry, G. Stem cell niches as clinical targets: the future of anti–ischemic therapy? Nat. Clin. Pract. Cardiovasc. Med.？2008, 5, 590–591, doi:10.1038/ncpcardio1295. 18628773
[165]
Cedazo–Minguez, A. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. JCMM？2007, 11, 1227–1238. 18205697
[166]
Mas, E.; Dupuy, A.M.; Artero, S.; Portet, F.; Cristol, J.P.; Ritchie, K.; Touchon, J. Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord.？2006, 21, 198–204, doi:10.1159/000090868. 16407653
[167]
Sanchez–Mejia, R.O.; Newman, J.W.; Toh, S.; Yu, G.Q.; Zhou, Y.; Halabisky, B.; Cisse, M.; Scearce–Levie, K.; Cheng, I.H.; Gan, L.; Palop, J.J.; Bonventre, J.V.; Mucke, L. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat. Neurosci.？2008, 11, 1311–1318, doi:10.1038/nn.2213. 18931664
[168]
Anekonda, T.S.; Reddy, P.H. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Brain Res. Brain Res. Rev.？2005, 50, 361–376. 16263176
[169]
Aliev, G.; Castellani, R.J.; Petersen, R.B.; Burnstock, G.; Perry, G.; Smith, M.A. Pathobiology of familial hypercholesterolemic atherosclerosis. J. Submicrosc. Cytol. Pathol.？2004, 36, 225–240. 15906597
[170]
Mahley, R.W.; Weisgraber, K.H.; Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. USA？2006, 103, 5644–5651, doi:10.1073/pnas.0600549103.
[171]
Reiman, E.M.; Caselli, R.J.; Chen, K.; Alexander, G.E.; Bandy, D.; Frost, J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. USA？2001, 98, 3334–3339, doi:10.1073/pnas.061509598.
[172]
Aliev, G.; Smith, M.A.; de la Torre, J.C.; Perry, G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion？2004, 4, 649–663, doi:10.1016/j.mito.2004.07.018. 16120422
